GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $31,642,000 | +15.7% | 464,630 | -45.7% | 0.00% | 0.0% |
| Q2 2022 | $27,359,000 | +38.9% | 856,299 | +50.6% | 0.00% | +33.3% |
| Q1 2022 | $19,694,000 | +234.9% | 568,539 | +183.1% | 0.00% | +200.0% |
| Q4 2021 | $5,880,000 | -25.8% | 200,858 | -35.5% | 0.00% | 0.0% |
| Q3 2021 | $7,929,000 | -58.8% | 311,243 | -43.4% | 0.00% | -66.7% |
| Q2 2021 | $19,260,000 | +169.2% | 549,982 | +213.2% | 0.00% | +200.0% |
| Q1 2021 | $7,155,000 | -39.5% | 175,580 | -35.7% | 0.00% | -50.0% |
| Q4 2020 | $11,819,000 | +95.9% | 272,907 | +149.5% | 0.00% | +100.0% |
| Q3 2020 | $6,032,000 | +13.7% | 109,392 | +30.2% | 0.00% | 0.0% |
| Q2 2020 | $5,304,000 | -74.2% | 84,019 | -79.1% | 0.00% | -83.3% |
| Q1 2020 | $20,531,000 | +2.3% | 401,851 | +59.2% | 0.01% | +20.0% |
| Q4 2019 | $20,062,000 | +243.4% | 252,378 | +109.6% | 0.01% | +150.0% |
| Q3 2019 | $5,843,000 | -28.8% | 120,428 | -22.8% | 0.00% | 0.0% |
| Q2 2019 | $8,210,000 | -4.1% | 156,072 | -3.5% | 0.00% | 0.0% |
| Q1 2019 | $8,565,000 | -16.8% | 161,804 | -35.5% | 0.00% | -33.3% |
| Q4 2018 | $10,299,000 | -4.7% | 250,881 | -11.8% | 0.00% | 0.0% |
| Q3 2018 | $10,806,000 | -3.8% | 284,382 | +14.4% | 0.00% | 0.0% |
| Q2 2018 | $11,232,000 | -38.0% | 248,504 | -33.8% | 0.00% | -40.0% |
| Q1 2018 | $18,124,000 | +46.7% | 375,247 | +19.5% | 0.01% | +66.7% |
| Q4 2017 | $12,352,000 | -6.9% | 313,911 | -26.6% | 0.00% | -25.0% |
| Q3 2017 | $13,273,000 | +13.5% | 427,488 | -0.0% | 0.00% | 0.0% |
| Q2 2017 | $11,694,000 | -52.6% | 427,568 | -36.2% | 0.00% | 0.0% |
| Q1 2017 | $24,680,000 | +512.1% | 669,744 | +140.0% | 0.00% | +300.0% |
| Q4 2016 | $4,032,000 | +539.0% | 279,098 | +919.0% | 0.00% | – |
| Q3 2016 | $631,000 | -47.8% | 27,390 | -62.4% | 0.00% | – |
| Q2 2016 | $1,209,000 | +104.6% | 72,872 | +95.5% | 0.00% | – |
| Q1 2016 | $591,000 | +515.6% | 37,279 | +1159.0% | 0.00% | – |
| Q4 2015 | $96,000 | -97.4% | 2,961 | -96.6% | 0.00% | -100.0% |
| Q3 2015 | $3,628,000 | – | 86,057 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |